芬兰医疗体系中自体乳房再造的中期总费用高于植入物再造:回顾性中期病例对照队列研究
该回顾性中期病例对照队列研究纳入2008至2019年间591例自体乳房再造和202例植入物乳房再造患者,随访中位73个月。
要点
- 自体乳房再造的中期总费用显著高于植入物再造($22 052 vs. $18 329,P<0.001)。
- 植入物再造更常需要两次或以上计划手术(P=0.008),但总手术率无显著差异(P=0.098)。
- 年轻(P<0.001)和合并症(P=0.008)是多次手术的独立危险因素。
核心结论
- 在芬兰医疗体系中,自体乳房再造与更高的中期总体费用相关,但再造时间或手术率无统计学显著差异。
- 全面评估不同再造技术的费用需要更长的随访期。
研究设计与样本
- 回顾性中期病例对照队列研究,回顾2008至2019年再造数据库。
- 纳入591例自体再造(DIEP、TMG、无植入物的LD)和202例植入物再造(植入物及带植入物的LD)患者,中位随访73个月。
主要发现
- 植入物再造确定再造时间为443天,自体再造为403天(P=0.050)。
- 多次手术的独立危险因素为年轻(P<0.001)和合并症(P=0.008)。
- 总手术率无统计学显著差异(P=0.098),但植入物再造更常与两次或以上计划手术相关(P=0.008)。
- 自体再造总费用更高($22 052 vs. $18 329,P<0.001)。
临床怎么用
- 临床决策需权衡自体再造的较高中期费用与植入物再造更常需多次计划手术的特点。
- 对年轻及有合并症患者应关注多次手术风险,加强围手术期评估与沟通。
局限性
- 作者指出全面评估再造技术费用需要更长的随访期。
- 本研究为回顾性设计,可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Previous studies have mainly reported the short-term costs of different reconstruction techniques. Revision operations may increase costs in longer follow-up. Authors report medium-term data on different reconstruction methods. We hypothesised that the reconstruction method would affect not only the duration of reconstruction process but also total costs. METHODS: The reconstruction database was reviewed from 2008 to 2019. Women with autologous (deep inferior epigastric perforator, transverse musculocutaneous gracilis and latissimus dorsi [LD] without implant) and implant-based (implant and LD with implant) reconstructions were included. Variables evaluated included age, body mass index, smoking, comorbidities, radiotherapy, complications and readmissions. Risk factors for multiple revision surgeries were analysed. Time to definitive reconstruction and related costs were also calculated. RESULTS: In total, 591 patients with autologous reconstructions and 202 with implant-based reconstructions were included. The median follow-up time was 73 months. Definitive reconstruction was obtained in 443 days in implant-based reconstructions and in 403 days in autologous reconstructions (P = 0.050). Independent risk factors for multiple surgeries were younger age (P < 0.001) and comorbidity (P = 0.008). No statistically significant difference was observed in the rate of overall surgical procedures (P = 0.098), but implant-based reconstructions were more commonly associated with two or more planned operations (P = 0.008). Autologous reconstructions were associated with greater total cost ($22 052 vs. $18 329, P < 0.001). CONCLUSIONS: This review of reconstructions over a 12-year study period revealed that autologous reconstructions are associated with greater overall costs, but there is no statistically significant difference in reconstruction time or rate of surgical procedures. However, a full cost assessment between reconstructive techniques requires a much longer follow-up period.
引用
- Palve JS, Luukkaala TH, Kääriäinen MT, et al. Autologous reconstructions are associated with greater overall medium-term care costs than implant-based reconstructions in the Finnish healthcare system: A retrospective interim case-control cohort study. J Plast Reconstr Aesthet Surg. 2021. PMID: 34627717. doi:10.1016/j.bjps.2021.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。